From financialisation to innovation in UK Big Pharma : AstraZeneca and GlaxoSmithKline / Oner Tulum, Antonio Andreoni, William Lazonick
Material type:![Computer file](/opac-tmpl/lib/famfamfam/CF.png)
- 9781009278140
- HD 9667.9.A78 T84F 2022
Contents:
1. Introduction -- 2. Innovation and Competition in the Global Pharmaceutical Industry -- 3. The Innovation-Financialisation Tension in the Global Pharmaceutical Industry -- 4. AstraZeneca -- 5. GlaxoSmithKline -- 6. Explaining the Financialisation-to-Innovation Transition at AstraZeneca and GlaxoSmithKline
Item type | Current library | Collection | Shelving location | Call number | Status | Date due | Barcode | Item holds | |
---|---|---|---|---|---|---|---|---|---|
![]() |
SPU Library, Bangkok (Main Campus) | Electronic Resources | On Display | HD 9667.9.A78 T84F 2022 (Browse shelf(Opens below)) | Available | EB000395 |
Total holds: 0
Title from publisher's bibliographic system (viewed on 30 Nov 2022)
1. Introduction -- 2. Innovation and Competition in the Global Pharmaceutical Industry -- 3. The Innovation-Financialisation Tension in the Global Pharmaceutical Industry -- 4. AstraZeneca -- 5. GlaxoSmithKline -- 6. Explaining the Financialisation-to-Innovation Transition at AstraZeneca and GlaxoSmithKline
There are no comments on this title.
Log in to your account to post a comment.